GSK2256098 Uses, Dosage, Side Effects and more
GSK2256098 is under investigation in clinical trial NCT02523014 (Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas).
| Trade Name | GSK2256098 |
| Generic | GSK2256098 |
| Type | |
| Formula | C20H23ClN6O2 |
| Weight | Average: 414.89 Monoisotopic: 414.1571017 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
